Candida Cristina Quarta - hubXchange

Loading

Candida Cristina Quarta - Alexion Pharmaceuticals

Candida Cristina Quarta

Executive Director, Alexion Pharmaceuticals

Sessions

28-Apr-2026

15:45 – 16:45
Understanding the biology in both tumor (site of efficacy) and normal (sites of potential dose limiting toxicity), & understanding how to tailor the linker to that biology [Topic TBC]